Clinical trial

Eicosapentaenoic Acid Serum Levels in Patients With Gestational Diabetes

NCT05591664

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention eicosapentaenoic acid Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Eicosapentaenoic Acid Serum Levels in Patients With Gestational Diabetes

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2022-10-17

PhaseN/A

Conditions

Gestational Diabetesverified · MONDO: gestational diabetes

Interventions

eicosapentaenoic acidDIAGNOSTIC_TEST

Sponsors & collaborators

Recep Tayyip Erdogan University Training and Research Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05591664 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.